PharmaSGP Holding SE (PSG.DE)
EUR 24.6
(0.82%)
EUR 24.6
(0.82%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 101.09 Million EUR | 17.8% |
| 2022 | 85.82 Million EUR | 31.34% |
| 2021 | 65.34 Million EUR | 3.32% |
| 2020 | 63.24 Million EUR | 1.07% |
| 2019 | 62.57 Million EUR | 3.27% |
| 2018 | 60.59 Million EUR | 14.2% |
| 2017 | 53.06 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 30.2 Million EUR | 18.81% |
| 2024 Q2 | 28.16 Million EUR | -6.76% |
| 2023 Q2 | 25.69 Million EUR | 7.03% |
| 2023 Q1 | 24.01 Million EUR | 9.75% |
| 2023 FY | 101.09 Million EUR | 17.8% |
| 2023 Q4 | 25.42 Million EUR | -2.09% |
| 2023 Q3 | 25.96 Million EUR | 1.04% |
| 2022 Q4 | 21.87 Million EUR | -0.34% |
| 2022 Q3 | 21.95 Million EUR | 2.45% |
| 2022 Q2 | 21.42 Million EUR | 4.17% |
| 2022 Q1 | 20.56 Million EUR | 7.24% |
| 2022 FY | 85.82 Million EUR | 31.34% |
| 2021 Q1 | 12.35 Million EUR | -15.93% |
| 2021 Q4 | 19.17 Million EUR | -2.81% |
| 2021 Q3 | 19.73 Million EUR | 40.15% |
| 2021 FY | 65.34 Million EUR | 3.32% |
| 2021 Q2 | 14.08 Million EUR | 14.02% |
| 2020 Q2 | 17.07 Million EUR | 1.99% |
| 2020 FY | 63.24 Million EUR | 1.07% |
| 2020 Q4 | 14.69 Million EUR | -0.39% |
| 2020 Q3 | 14.74 Million EUR | -13.61% |
| 2020 Q1 | 16.73 Million EUR | -0.68% |
| 2019 Q1 | 14.95 Million EUR | 0.0% |
| 2019 FY | 62.57 Million EUR | 3.27% |
| 2019 Q4 | 16.85 Million EUR | 18.92% |
| 2019 Q3 | 14.17 Million EUR | -14.61% |
| 2019 Q2 | 16.59 Million EUR | 10.97% |
| 2018 FY | 60.59 Million EUR | 14.2% |
| 2017 FY | 53.06 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| MPH Health Care AG | 34.43 Million EUR | -193.632% |
| Apontis Pharma AG | 36.96 Million EUR | -173.508% |
| Dermapharm Holding SE | 1.13 Billion EUR | 91.095% |
| Evotec SE | 781.42 Million EUR | 87.062% |
| MERCK Kommanditgesellschaft auf Aktien | 20.99 Billion EUR | 99.518% |
| SynBiotic SE | 3.86 Million EUR | -2518.225% |